These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24360837)

  • 1. High-resolution chemical dissection of a model eukaryote reveals targets, pathways and gene functions.
    Hoepfner D; Helliwell SB; Sadlish H; Schuierer S; Filipuzzi I; Brachat S; Bhullar B; Plikat U; Abraham Y; Altorfer M; Aust T; Baeriswyl L; Cerino R; Chang L; Estoppey D; Eichenberger J; Frederiksen M; Hartmann N; Hohendahl A; Knapp B; Krastel P; Melin N; Nigsch F; Oakeley EJ; Petitjean V; Petersen F; Riedl R; Schmitt EK; Staedtler F; Studer C; Tallarico JA; Wetzel S; Fishman MC; Porter JA; Movva NR
    Microbiol Res; 2014; 169(2-3):107-20. PubMed ID: 24360837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring gene function and drug action using chemogenomic dosage assays.
    Ericson E; Hoon S; St Onge RP; Giaever G; Nislow C
    Methods Enzymol; 2010; 470():233-55. PubMed ID: 20946813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel calcineurin-independent activity of cyclosporin A in Saccharomyces cerevisiae.
    Singh-Babak SD; Shekhar T; Smith AM; Giaever G; Nislow C; Cowen LE
    Mol Biosyst; 2012 Oct; 8(10):2575-84. PubMed ID: 22751784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical-genetic approaches for exploring the mode of action of natural products.
    Lopez A; Parsons AB; Nislow C; Giaever G; Boone C
    Prog Drug Res; 2008; 66():237, 239-71. PubMed ID: 18416308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel equisetin-like compound, TA-289, causes aberrant mitochondrial morphology which is independent of the production of reactive oxygen species in Saccharomyces cerevisiae.
    Quek NC; Matthews JH; Bloor SJ; Jones DA; Bircham PW; Heathcott RW; Atkinson PH
    Mol Biosyst; 2013 Aug; 9(8):2125-33. PubMed ID: 23715404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of yeast genes that confer resistance to chitosan oligosaccharide (COS) using chemogenomics.
    Jaime MD; Lopez-Llorca LV; Conesa A; Lee AY; Proctor M; Heisler LE; Gebbia M; Giaever G; Westwood JT; Nislow C
    BMC Genomics; 2012 Jun; 13():267. PubMed ID: 22727066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Screens for Determination of Mechanism of Action.
    Gay-Andrieu F; Alex D; Calderone R
    Methods Mol Biol; 2016; 1356():165-72. PubMed ID: 26519072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A drug similarity network for understanding drug mechanism of action.
    Karabulut NP; Akhmedov M; Cokol M
    J Bioinform Comput Biol; 2014 Apr; 12(2):1441007. PubMed ID: 24712534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-species chemogenomic profiling reveals evolutionarily conserved drug mode of action.
    Kapitzky L; Beltrao P; Berens TJ; Gassner N; Zhou C; Wüster A; Wu J; Babu MM; Elledge SJ; Toczyski D; Lokey RS; Krogan NJ
    Mol Syst Biol; 2010 Dec; 6():451. PubMed ID: 21179023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network-assisted target identification for haploinsufficiency and homozygous profiling screens.
    Wang S; Peng J
    PLoS Comput Biol; 2017 Jun; 13(6):e1005553. PubMed ID: 28574983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of drug targets by chemogenomic and metabolomic profiling in yeast.
    Wu M; Zheng M; Zhang W; Suresh S; Schlecht U; Fitch WL; Aronova S; Baumann S; Davis R; St Onge R; Dill DL; Peltz G
    Pharmacogenet Genomics; 2012 Dec; 22(12):877-86. PubMed ID: 23076370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and evaluation of novel acetolactate synthase inhibitors as antifungal agents.
    Richie DL; Thompson KV; Studer C; Prindle VC; Aust T; Riedl R; Estoppey D; Tao J; Sexton JA; Zabawa T; Drumm J; Cotesta S; Eichenberger J; Schuierer S; Hartmann N; Movva NR; Tallarico JA; Ryder NS; Hoepfner D
    Antimicrob Agents Chemother; 2013 May; 57(5):2272-80. PubMed ID: 23478965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing Approach Identifies Auranofin with Broad Spectrum Antifungal Activity That Targets Mia40-Erv1 Pathway.
    Thangamani S; Maland M; Mohammad H; Pascuzzi PE; Avramova L; Koehler CM; Hazbun TR; Seleem MN
    Front Cell Infect Microbiol; 2017; 7():4. PubMed ID: 28149831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemogenomic profiling: identifying the functional interactions of small molecules in yeast.
    Giaever G; Flaherty P; Kumm J; Proctor M; Nislow C; Jaramillo DF; Chu AM; Jordan MI; Arkin AP; Davis RW
    Proc Natl Acad Sci U S A; 2004 Jan; 101(3):793-8. PubMed ID: 14718668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond synexpression relationships: local clustering of time-shifted and inverted gene expression profiles identifies new, biologically relevant interactions.
    Qian J; Dolled-Filhart M; Lin J; Yu H; Gerstein M
    J Mol Biol; 2001 Dec; 314(5):1053-66. PubMed ID: 11743722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Mini HIP HOP Assay Uncovers a Central Role for Copper and Zinc in the Antifungal Mode of Action of Allicin.
    Prescott TAK; Panaretou B
    J Agric Food Chem; 2017 May; 65(18):3659-3664. PubMed ID: 28421744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A yeast strain biosensor to detect cell wall-perturbing agents.
    Rodriguez-Peña JM; Diez-Muñiz S; Nombela C; Arroyo J
    J Biotechnol; 2008 Feb; 133(3):311-7. PubMed ID: 18055054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A latent variable model for chemogenomic profiling.
    Flaherty P; Giaever G; Kumm J; Jordan MI; Arkin AP
    Bioinformatics; 2005 Aug; 21(15):3286-93. PubMed ID: 15919724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining current knowledge on the yeast FLR1 regulatory network by combined experimental and computational approaches.
    Teixeira MC; Dias PJ; Monteiro PT; Sala A; Oliveira AL; Freitas AT; Sá-Correia I
    Mol Biosyst; 2010 Dec; 6(12):2471-81. PubMed ID: 20938527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting drug-target interactions through integrative analysis of chemogenetic assays in yeast.
    Heiskanen MA; Aittokallio T
    Mol Biosyst; 2013 Apr; 9(4):768-79. PubMed ID: 23420501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.